These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2733097)

  • 21. Metastatic potential of human renal cell carcinoma: experimental model using subrenal capsule implantation in athymic nude mice.
    Grossi FS; Zhao X; Romijn JC; ten Kate FJ; Schröder FH
    Urol Res; 1992; 20(4):303-6. PubMed ID: 1509637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-tumor effect of human recombinant tumor necrosis factor on the human renal cell carcinoma serially transplanted into nude mice].
    Honda N; Yamada Y; Muramatsu T; Fukatsu H; Segawa A
    Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1613-21. PubMed ID: 3251094
    [No Abstract]   [Full Text] [Related]  

  • 23. Nanotechnology combined therapy: tyrosine kinase-bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model.
    Liu J; Abshire C; Carry C; Sholl AB; Mandava SH; Datta A; Ranjan M; Callaghan C; Peralta DV; Williams KS; Lai WR; Abdel-Mageed AB; Tarr M; Lee BR
    BJU Int; 2017 Feb; 119(2):342-348. PubMed ID: 27431021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study.
    Dabestani S; Thorstenson A; Lindblad P; Harmenberg U; Ljungberg B; Lundstam S
    World J Urol; 2016 Aug; 34(8):1081-6. PubMed ID: 26847337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human tumor necrosis factor alone and with chemotherapeutic agents. Effect on nude mouse-supported human bladder cancer heterografts.
    Das AK; Walther PJ; Buckley NJ; Poulton SH
    Arch Surg; 1989 Jan; 124(1):107-10. PubMed ID: 2910237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of high-energy shock waves combined with biological response modifiers in different human kidney cancer xenografts.
    Oosterhof GO; Smits GA; de Ruyter AE; Schalken JA; Debruyne FM
    Ultrasound Med Biol; 1991; 17(4):391-9. PubMed ID: 1949350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.
    Mickisch GH; Garin A; van Poppel H; de Prijck L; Sylvester R;
    Lancet; 2001 Sep; 358(9286):966-70. PubMed ID: 11583750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of recombinant tumor necrosis factor in cancer patients.
    Blick M; Sherwin SA; Rosenblum M; Gutterman J
    Cancer Res; 1987 Jun; 47(11):2986-9. PubMed ID: 3567916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha-Interferon and interleukin-2 in renal cell carcinoma: studies in nonhospitalized patients.
    Atzpodien J; Poliwoda H; Kirchner H
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):108-12. PubMed ID: 1948123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of combining recombinant human tumor necrosis factor-alpha with local radiation on tumor control probability of a human glioblastoma multiforme xenograft in nude mice.
    Huang P; Allam A; Perez LA; Taghian A; Freeman J; Suit HD
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):93-8. PubMed ID: 7721643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of molecular genetic markers to demonstrate the effect of organ environment on clonal dominance in a human renal-cell carcinoma grown in nude mice.
    Staroselsky AN; Radinsky R; Fidler IJ; Pathak S; Chernajovsky Y; Frost P
    Int J Cancer; 1992 Apr; 51(1):130-8. PubMed ID: 1563832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor.
    Figlin RA; Pierce WC; Kaboo R; Tso CL; Moldawer N; Gitlitz B; deKernion J; Belldegrun A
    J Urol; 1997 Sep; 158(3 Pt 1):740-5. PubMed ID: 9258071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor effect of recombinant tumor necrosis factor-alpha against murine sarcomas at visceral sites: tumor size influences the response to therapy.
    Mulé JJ; Asher A; McIntosh J; Lafreniere R; Shiloni E; Lefor A; Reichert CM; Rosenberg SA
    Cancer Immunol Immunother; 1988; 26(3):202-8. PubMed ID: 3383204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
    Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
    J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary toxicity of recombinant human tumor necrosis factor.
    Kuei JH; Tashkin DP; Figlin RA
    Chest; 1989 Aug; 96(2):334-8. PubMed ID: 2752816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma.
    Belldegrun A; Shvarts O; Figlin RA
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S88-92. PubMed ID: 10685666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
    Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
    Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients.
    Lopez Hänninen E; Kirchner H; Atzpodien J
    J Urol; 1996 Jan; 155(1):19-25. PubMed ID: 7490829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vivo anti-tumour efficacy of tumour necrosis factor and interferon- alpha, -gamma on human renal cell carcinoma heterotransplanted in nude mice].
    Onishi T; Machida T; Masuda F; Iizuka N; Nakauchi K; Furuta N; Shirakawa H
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1571-8. PubMed ID: 2121869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.